我们能帮助严重受伤的人止血吗?

James Piercy, Charlotte Lindsay, Ross Davenport
{"title":"我们能帮助严重受伤的人止血吗?","authors":"James Piercy, Charlotte Lindsay, Ross Davenport","doi":"10.3389/frym.2024.1352052","DOIUrl":null,"url":null,"abstract":"Serious bleeding, known as major hemorrhage, is the most common cause of death in people with serious injuries. People with major hemorrhage often have a lower amount of an important protein called fibrinogen in their blood, which makes it more difficult to stop the bleeding. In a big randomized controlled trial called CRYOSTAT 2, we looked at whether giving people extra fibrinogen soon after their injury helped stop bleeding and increased the number of people who survived. We were surprised to find that fibrinogen did not help as much as we expected, and that it may even make some people more likely to die. In this article, we talk about the CRYOSTAT-2 experiment and how it shows we cannot treat all bleeding patients in the same way.","PeriodicalId":503754,"journal":{"name":"Frontiers for Young Minds","volume":"27 29","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Can We Help Stop Bleeding in Badly Injured People\",\"authors\":\"James Piercy, Charlotte Lindsay, Ross Davenport\",\"doi\":\"10.3389/frym.2024.1352052\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Serious bleeding, known as major hemorrhage, is the most common cause of death in people with serious injuries. People with major hemorrhage often have a lower amount of an important protein called fibrinogen in their blood, which makes it more difficult to stop the bleeding. In a big randomized controlled trial called CRYOSTAT 2, we looked at whether giving people extra fibrinogen soon after their injury helped stop bleeding and increased the number of people who survived. We were surprised to find that fibrinogen did not help as much as we expected, and that it may even make some people more likely to die. In this article, we talk about the CRYOSTAT-2 experiment and how it shows we cannot treat all bleeding patients in the same way.\",\"PeriodicalId\":503754,\"journal\":{\"name\":\"Frontiers for Young Minds\",\"volume\":\"27 29\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers for Young Minds\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/frym.2024.1352052\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers for Young Minds","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/frym.2024.1352052","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

严重出血,即大出血,是重伤患者最常见的死亡原因。大出血患者血液中一种名为纤维蛋白原的重要蛋白质含量通常较低,这使得止血更加困难。在一项名为 "CRYOSTAT 2 "的大型随机对照试验中,我们研究了在人们受伤后不久给予他们额外的纤维蛋白原是否有助于止血并增加存活人数。我们惊讶地发现,纤维蛋白原的帮助并没有我们预期的那么大,它甚至可能使一些人更容易死亡。在本文中,我们将讨论 CRYOSTAT-2 实验,以及它如何表明我们不能用同样的方法治疗所有出血患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Can We Help Stop Bleeding in Badly Injured People
Serious bleeding, known as major hemorrhage, is the most common cause of death in people with serious injuries. People with major hemorrhage often have a lower amount of an important protein called fibrinogen in their blood, which makes it more difficult to stop the bleeding. In a big randomized controlled trial called CRYOSTAT 2, we looked at whether giving people extra fibrinogen soon after their injury helped stop bleeding and increased the number of people who survived. We were surprised to find that fibrinogen did not help as much as we expected, and that it may even make some people more likely to die. In this article, we talk about the CRYOSTAT-2 experiment and how it shows we cannot treat all bleeding patients in the same way.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信